Herein, we demonstrate that ChREBP is highly upregulated in mouse AML cells (as well as LICs) and acts as a tumor suppressor, rather than as an oncogene as previously reported, to inhibit the differentiation of LICs from a MLL-AF9-induced murine AML model. Here, MLXIPL is linked to neoplasm.